|
35
|
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
PAR-25-226 · National Institutes of Health · other
|
biomedical clinical
public health
mental behavioral health
|
— |
2024-11-22 |
2026-11-19 |
14 |
|
27
|
Venous Thrombosis (VT)
80JSC026Q0014 · NATIONAL AERONAUTICS AND SPACE ADMINISTRATION · NASA JOHNSON SPACE CENTER · other
|
biomedical clinical
public health
|
— |
2026-09-28 |
2026-11-20 |
15 |
|
18
|
RFI Lupus Research Program (LRP) Public
HT9427RFI2027LRP · DEFENSE HEALTH AGENCY (DHA) · DEFENSE HEALTH AGENCY · other
|
biomedical clinical
public health
social services
|
— |
2026-10-15 |
2026-11-16 |
11 |
|
17
|
Venous Thrombosis (VT)
80JSC026Q0014 · NATIONAL AERONAUTICS AND SPACE ADMINISTRATION · NASA JOHNSON SPACE CENTER · other
|
biomedical clinical
public health
|
— |
2026-09-25 |
2026-11-20 |
15 |
|
15
|
RFI Lupus Research Program (LRP) Public
HT9427RFI2027LRP · DEFENSE HEALTH AGENCY (DHA) · DEFENSE HEALTH AGENCY · other
|
biomedical clinical
public health
|
— |
2026-10-14 |
2026-11-16 |
11 |
|
15
|
Synthesis and Distribution of Drugs of Abuse and Related Compounds
75N98027R00006SB · NATIONAL INSTITUTES OF HEALTH · NATIONAL INSTITUTES OF HEALTH NIDA · other
|
biomedical clinical
public health
materials manufacturing
|
— |
2026-10-29 |
2026-11-20 |
15 |
|
15
|
OJP FY 2026 Integrity in American Elections Grant Program
O-BJA-2026-172793 · Bureau of Justice Assistance · other
|
justice law
public health
|
$5,000,000 |
2026-10-15 |
2026-12-01 |
26 |
|
15
|
RFI Alzheimer’s Research Program (AZRP) Public
HT9427RFI2027AZRP · DEFENSE HEALTH AGENCY (DHA) · DEFENSE HEALTH AGENCY · other
|
biomedical clinical
public health
mental behavioral health
|
— |
2026-10-27 |
2026-12-04 |
29 |